These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1685784

  • 1. Effects of morphine in the nucleus accumbens on stimulant-induced locomotion.
    Layer RT, Uretsky NJ, Wallace LJ.
    Pharmacol Biochem Behav; 1991 Sep; 40(1):21-6. PubMed ID: 1685784
    [Abstract] [Full Text] [Related]

  • 2. Effect of GABAergic transmission in the subpallidal region on the hypermotility response to the administration of excitatory amino acids and picrotoxin into the nucleus accumbens.
    Shreve PE, Uretsky NJ.
    Neuropharmacology; 1988 Dec; 27(12):1271-7. PubMed ID: 2907617
    [Abstract] [Full Text] [Related]

  • 3. alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs.
    Willins DL, Wallace LJ, Miller DD, Uretsky NJ.
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1145-51. PubMed ID: 1372049
    [Abstract] [Full Text] [Related]

  • 4. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA.
    Boldry RC, Willins DL, Wallace LJ, Uretsky NJ.
    Brain Res; 1991 Sep 13; 559(1):100-8. PubMed ID: 1685936
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions.
    Boldry RC, Layer RT, Wallace LJ, Uretsky NJ.
    Neurosci Lett; 1992 Apr 27; 138(2):265-9. PubMed ID: 1376874
    [Abstract] [Full Text] [Related]

  • 6. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.
    Mele A, Thomas DN, Pert A.
    Neuroscience; 1998 Jan 27; 82(1):43-58. PubMed ID: 9483502
    [Abstract] [Full Text] [Related]

  • 7. Role of quisqualic acid receptors in the hypermotility response produced by the injection of AMPA into the nucleus accumbens.
    Shreve PE, Uretsky NJ.
    Pharmacol Biochem Behav; 1988 Jun 27; 30(2):379-84. PubMed ID: 2902646
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A, Nieoullon A, Amalric M.
    Eur J Pharmacol; 1994 Jan 14; 251(2-3):229-36. PubMed ID: 8149978
    [Abstract] [Full Text] [Related]

  • 10. Sensitization of the locomotor response to psychostimulants after repeated opiate exposure: role of the nucleus accumbens.
    Cunningham ST, Finn M, Kelley AE.
    Neuropsychopharmacology; 1997 Feb 14; 16(2):147-55. PubMed ID: 9015797
    [Abstract] [Full Text] [Related]

  • 11. NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.
    Boldry RC, Kelland MD, Engber TM, Chase TN.
    Brain Res; 1993 Jan 15; 600(2):331-4. PubMed ID: 7679606
    [Abstract] [Full Text] [Related]

  • 12. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
    De Leonibus E, Mele A, Oliverio A, Pert A.
    Neuroscience; 2001 Jan 15; 104(1):105-16. PubMed ID: 11311535
    [Abstract] [Full Text] [Related]

  • 13. AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.
    Kaddis FG, Wallace LJ, Uretsky NJ.
    Pharmacol Biochem Behav; 1993 Nov 15; 46(3):703-8. PubMed ID: 7506423
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of metabotropic but not ionotropic glutamatergic receptors in the nucleus accumbens is required for the D-amphetamine-induced release of functional dopamine.
    Darracq L, Drouin C, Blanc G, Glowinski J, Tassin JP.
    Neuroscience; 2001 Nov 15; 103(2):395-403. PubMed ID: 11246154
    [Abstract] [Full Text] [Related]

  • 15. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801.
    Willins DL, Narayanan S, Wallace LJ, Uretsky NJ.
    Pharmacol Biochem Behav; 1993 Dec 15; 46(4):881-7. PubMed ID: 8309969
    [Abstract] [Full Text] [Related]

  • 16. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion.
    Deroche V, Marinelli M, Maccari S, Le Moal M, Simon H, Piazza PV.
    J Neurosci; 1995 Nov 15; 15(11):7181-8. PubMed ID: 7472472
    [Abstract] [Full Text] [Related]

  • 17. Injections of D-amphetamine into the ventral pallidum increase locomotor activity and responding for conditioned reward: a comparison with injections into the nucleus accumbens.
    Fletcher PJ, Korth KM, Sabijan MS, DeSousa NJ.
    Brain Res; 1998 Sep 14; 805(1-2):29-40. PubMed ID: 9733910
    [Abstract] [Full Text] [Related]

  • 18. Folate induced-hypermotility response after bilateral injection into the nucleus accumbens of the rat. Possible mediation through dopaminergic mechanisms.
    Stephens RL, Uretsky NJ.
    Neuropharmacology; 1986 Aug 14; 25(8):887-96. PubMed ID: 3022181
    [Abstract] [Full Text] [Related]

  • 19. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors.
    Bardgett ME, Henry JD.
    Neuroscience; 1999 Aug 14; 94(1):59-70. PubMed ID: 10613497
    [Abstract] [Full Text] [Related]

  • 20. Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats.
    Bespalov AY, Zvartau EE.
    Pharmacol Biochem Behav; 1996 Oct 14; 55(2):203-7. PubMed ID: 8951955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.